296 related articles for article (PubMed ID: 25487356)
1. Differentiation of hemangioblastomas from pilocytic astrocytomas using 3-T magnetic resonance perfusion-weighted imaging and MR spectroscopy.
She DJ; Xing Z; Zeng Z; Shang XY; Cao DR
Neuroradiology; 2015 Mar; 57(3):275-81. PubMed ID: 25487356
[TBL] [Abstract][Full Text] [Related]
2. Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging.
Zonari P; Baraldi P; Crisi G
Neuroradiology; 2007 Oct; 49(10):795-803. PubMed ID: 17619871
[TBL] [Abstract][Full Text] [Related]
3. Comparison of perfusion, diffusion, and MR spectroscopy between low-grade enhancing pilocytic astrocytomas and high-grade astrocytomas.
de Fatima Vasco Aragao M; Law M; Batista de Almeida D; Fatterpekar G; Delman B; Bader AS; Pelaez M; Fowkes M; Vieira de Mello R; Moraes Valenca M
AJNR Am J Neuroradiol; 2014 Aug; 35(8):1495-502. PubMed ID: 24699088
[TBL] [Abstract][Full Text] [Related]
4. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
5. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance dynamic susceptibility-weighted contrast-enhanced perfusion imaging in the diagnosis of posterior fossa hemangioblastomas and pilocytic astrocytomas: initial results.
Kumar VA; Knopp EA; Zagzag D
J Comput Assist Tomogr; 2010; 34(6):825-9. PubMed ID: 21084895
[TBL] [Abstract][Full Text] [Related]
7. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
8. Role of proton magnetic resonance spectroscopy in differentiating oligodendrogliomas from astrocytomas.
Chawla S; Oleaga L; Wang S; Krejza J; Wolf RL; Woo JH; O'Rourke DM; Judy KD; Grady MS; Melhem ER; Poptani H
J Neuroimaging; 2010 Jan; 20(1):3-8. PubMed ID: 19021846
[TBL] [Abstract][Full Text] [Related]
9. MR dynamic-susceptibility-contrast perfusion metrics in the presurgical discrimination of adult solitary intra-axial cerebellar tumors.
Pons-Escoda A; Garcia-Ruiz A; Garcia-Hidalgo C; Gil-Solsona R; Naval-Baudin P; Martin-Noguerol T; Fernandez-Coello A; Flores-Casaperalta S; Fernandez-Viñas M; Gago-Ferrero P; Oleaga L; Perez-Lopez R; Majos C
Eur Radiol; 2023 Dec; 33(12):9120-9129. PubMed ID: 37439938
[TBL] [Abstract][Full Text] [Related]
10. Proton MR spectroscopy in predicting the increase of perfusion MR imaging for WHO grade II gliomas.
Guillevin R; Menuel C; Abud L; Costalat R; Capelle L; Hoang-Xuan K; Habas C; Chiras J; Vallée JN
J Magn Reson Imaging; 2012 Mar; 35(3):543-50. PubMed ID: 22045581
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
12. Differentiating Hemangioblastomas from Brain Metastases Using Diffusion-Weighted Imaging and Dynamic Susceptibility Contrast-Enhanced Perfusion-Weighted MR Imaging.
She D; Yang X; Xing Z; Cao D
AJNR Am J Neuroradiol; 2016 Oct; 37(10):1844-1850. PubMed ID: 27173365
[TBL] [Abstract][Full Text] [Related]
13. [Perfusion magnetic resonance imaging for high grade astrocytomas: Can cerebral blood volume, peak height, and percentage of signal intensity recovery distinguish between progression and pseudoprogression?].
Martínez-Martínez A; Martínez-Bosch J
Radiologia; 2014; 56(1):35-43. PubMed ID: 23790618
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of perfusion weighted magnetic resonance imaging with signal-intensity curves analysis in the differential diagnosis of sellar and parasellar tumors: preliminary report.
Bladowska J; Zimny A; Guziński M; Hałoń A; Tabakow P; Czyż M; Czapiga B; Jarmundowicz W; Sąsiadek MJ
Eur J Radiol; 2013 Aug; 82(8):1292-8. PubMed ID: 23466030
[TBL] [Abstract][Full Text] [Related]
15. Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors.
Bulakbasi N; Kocaoglu M; Ors F; Tayfun C; Uçöz T
AJNR Am J Neuroradiol; 2003 Feb; 24(2):225-33. PubMed ID: 12591638
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging and spectroscopy of pilomyxoid astrocytomas: case reports and comparison with pilocytic astrocytomas.
Morales H; Kwock L; Castillo M
J Comput Assist Tomogr; 2007; 31(5):682-7. PubMed ID: 17895777
[TBL] [Abstract][Full Text] [Related]
17. The role of diffusion and perfusion magnetic resonance imaging in differentiation of haemangioblastomas and pilocytic astrocytomas.
Neska-Matuszewska M; Zimny A; Bladowska J; Czarnecka A; Sąsiadek M
Pol J Radiol; 2018; 83():e197-e203. PubMed ID: 30627235
[TBL] [Abstract][Full Text] [Related]
18. Differentiation between oligodendroglioma genotypes using dynamic susceptibility contrast perfusion-weighted imaging and proton MR spectroscopy.
Chawla S; Krejza J; Vossough A; Zhang Y; Kapoor GS; Wang S; O'Rourke DM; Melhem ER; Poptani H
AJNR Am J Neuroradiol; 2013 Aug; 34(8):1542-9. PubMed ID: 23370479
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy.
Di Costanzo A; Scarabino T; Trojsi F; Giannatempo GM; Popolizio T; Catapano D; Bonavita S; Maggialetti N; Tosetti M; Salvolini U; d'Angelo VA; Tedeschi G
Neuroradiology; 2006 Sep; 48(9):622-31. PubMed ID: 16752135
[TBL] [Abstract][Full Text] [Related]
20. Combined value of susceptibility-weighted and perfusion-weighted imaging in assessing who grade for brain astrocytomas.
Wang XC; Zhang H; Tan Y; Qin JB; Wu XF; Wang L; Zhang L
J Magn Reson Imaging; 2014 Jun; 39(6):1569-74. PubMed ID: 24987755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
